


Advent France Biotechnology participe au tour de table de Série B de 74M$ (61,5M€) d’AgomAb Therapeutics

Advent France Biotechnology crée Gamut Therapeutics et finance son amorçage

QuantaMatrix debuts on KOSDAQ on Dec 9 as IPO prices at high end, raising USD 40.2M

Kayentis raises €7M ($8.3M) to accelerate the global expansion of its digital platform for clinical trials

European Investment Bank provides Minoryx with up to €25 million to support development of breakthrough therapies in orphan neurodegenerative diseases

CarThera to receive €2M grant and €10.5M equity from the European Innovation Council

TiHive awarded €8.6M in EU funding for transformational AI-terahertz defect detection technology

Arthex secures €4.25M from Invivo Ventures and Advent France Biotechnology
